Julia Marie Eastland - 08 Nov 2021 Form 4 Insider Report for Harpoon Therapeutics, Inc.

Role
President and CEO, Director
Signature
/s/ Julie Eastland by Laura Berezin, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
08 Nov 2021
Net transactions value
$0
Form type
4
Filing time
09 Nov 2021, 15:02:22 UTC
Previous filing
04 Jun 2021
Next filing
27 May 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HARP Stock Option (Right to Buy) Award $0 +350,000 $0.000000 350,000 08 Nov 2021 Common Stock 350,000 $6.85 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Twenty-five percent of the stock option shall be fully vested and exercisable on the first anniversary of the vesting commencement date, November 8, 2022, and the remaining seventy-five percent shall vest over the following three years in equal monthly installments.